Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
1h
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Moderna
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP ( www.faruqilaw.com ). Prior ...
McKnight's Long-Term Care News
21m
RSV vaccine still 43.3 percent effective 3 years after people take it, trial shows
GSK announced on Tuesday that a single dose of its Arexvy vaccine against respiratory syncytial virus (RSV) was 43.3% ...
FierceBiotech
27m
'Ongoing challenges' force Pfizer to scrap oral RSV med from ReViral buyout
In another blow to its $525 million buyout of ReViral, Pfizer has ended development of sisunatovir, an oral inhibitor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Human life expectancy study
To campaign for Harris
More troops to Ukraine?
First deputy mayor resigns
Florida orders evacuations
Jets fire head coach Saleh
US deficit hits $1.8 trillion
Kemp suspends GA mayor
Sex abuse case dismissed
Richest female musician
To replace lead water pipes
Harris on '60 Minutes'
Tickets to climb to $5
Rwandan virus screening
Athlete payments approval
States sue TikTok
Ordered to open app store
Hears ghost gun rule case
Israel expands offensive
US overdose deaths drop
Settles latest civil lawsuit
Hamas backers sanctioned
Former aide charged
Targeted by a cyberattack
Liquidation plan approved
Win Nobel Prize in physics
Hera mission launched
SCOTUS denies appeal
Intel defensive briefings rise
Medical copter crash kills 3
Related topics
GSK
United States
COVID-19
Pfizer
Centers for Disease Control and Prevention
Feedback